Myotis bat genomes link extended lifespan to enhanced immune gene dosage and apoptosis bias

{"Researchers led by Juan Manuel Vazquez at UC Berkeley assembled and compared high-quality genomes from eight Myotis bats, several of which exceed 30-year lifespans despite small body size. They quantified gene-family expansions and performed functional assays on primary fibroblasts exposed to lethal doses of a DNA-damaging agent. Longer-lived species displayed higher copy numbers of genes involved in innate immunity and cancer surveillance; after damage, these cells preferentially activated pro-apoptotic programs instead of DNA-repair transcripts.","The pattern mirrors the elephant p53 amplification strategy but evolved independently, indicating convergent selection on cell-quality control. Overlap between aging-associated and pathogen-defense loci suggests shared regulatory architecture that may allow bats to maintain immune vigilance without chronic inflammation. The study therefore reframes immunosenescence and cancer as coupled processes addressable through the same molecular nodes.","Current human trials targeting senescence-associated secretory phenotype or CAR-T rejuvenation could be informed by bat-specific apoptosis thresholds. However, the dataset remains limited to eight species and in-vitro conditions; larger phylogenomic sampling and in-vivo validation are required before translation. Future work should test whether bat-derived apoptosis regulators extend healthspan in mouse models within defined dose ranges.","If replicated across additional long-lived mammals, these findings would shift longevity research from single-pathway interventions toward systems-level immune tuning calibrated to species-specific damage thresholds."}